Klotho Neurosciences, Inc. (NASDAQ:KLTO) filed a Form 8-K with the Securities and Exchange Commission on February 17, 2026, disclosing a material event.
Klotho Neurosciences, Inc.'s stock currently trades at $0.22 with a market capitalization of $22.5M. The Healthcare company's stock moved following the disclosure.